Literature DB >> 11864338

Frequency and molecular diversity of Pseudomonas aeruginosa upon admission and during hospitalization: a prospective epidemiologic study.

Dominique S. Blanc1, Christiane Petignat, Béatrice Janin, Jacques Bille, Patrick Francioli.   

Abstract

OBJECTIVE: To assess the molecular epidemiology and risk factors for Pseudomonas aeruginosa colonization and infection in hospitalized patients.
METHODS: In a 1000-bed university hospital, newly admitted patients were assessed prospectively for colonization and infection with P. aeruginosa. Anal swabs were obtained upon admission and at discharge. Ribotyping was used for the typing of isolates. Epidemiologic and clinical data were recorded prospectively. Independent risk factors were assessed using multivariate analysis.
RESULTS: The recovery rate of patients with P. aeruginosa from anal specimens on admission was 6.7% (42/628). Infection due to P. aeruginosa was observed in 20 of 628 (3.2%) patients, of whom 10 (1.6%) were already infected on admission. Independent risk factors for colonization/infection on admission were age, indwelling urinary catheter, the presence of wound and seropositivity for HIV. Independent risk factors for nosocomial infection were anal colonization on admission, alcoholism, indwelling urinary catheter and antibiotic treatment during hospitalization. Ribotyping revealed that 27 patients were colonized or infected with a unique ribotype, whereas 24 shared one or more ribotypes with other patients. Analysis of epidemiologic and molecular typing data revealed that transmission from patients to patients or from patients to environment was documented on only three occasions.
CONCLUSIONS: A great many P. aeruginosa strains were isolated from patients and the environment, and most environmental strains were different from those recovered in patients, suggesting a low rate of hospital acquisition of P. aeruginosa from the environment. The main risk factors for hospital-acquired infection were detectable colonization on admission, antibiotic treatment and urinary catheter.

Entities:  

Year:  1998        PMID: 11864338     DOI: 10.1111/j.1469-0691.1998.tb00051.x

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN: 1198-743X            Impact factor:   8.067


  18 in total

1.  Persistent colonization and the spread of antibiotic resistance in nosocomial pathogens: resistance is a regional problem.

Authors:  David L Smith; Jonathan Dushoff; Eli N Perencevich; Anthony D Harris; Simon A Levin
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-25       Impact factor: 11.205

2.  Role of hospital stay and antibiotic use on Pseudomonas aeruginosa gastrointestinal colonization in hospitalized patients.

Authors:  D Lepelletier; N Caroff; D Riochet; P Bizouarn; A Bourdeau; F Le Gallou; E Espaze; A Reynaud; H Richet
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2006-09       Impact factor: 3.267

3.  Wavelength-normalized spectroscopic analysis of Staphylococcus aureus and Pseudomonas aeruginosa growth rates.

Authors:  Samantha E McBirney; Kristy Trinh; Annie Wong-Beringer; Andrea M Armani
Journal:  Biomed Opt Express       Date:  2016-09-14       Impact factor: 3.732

4.  Molecular epidemiology of Pseudomonas aeruginosa colonization in a burn unit: persistence of a multidrug-resistant clone and a silver sulfadiazine-resistant clone.

Authors:  Jean-Paul Pirnay; Daniel De Vos; Christel Cochez; Florence Bilocq; Jean Pirson; Marc Struelens; Luc Duinslaeger; Pierre Cornelis; Martin Zizi; Alain Vanderkelen
Journal:  J Clin Microbiol       Date:  2003-03       Impact factor: 5.948

5.  Assessing the emergence of resistance: the absence of biological cost in vivo may compromise fosfomycin treatments for P. aeruginosa infections.

Authors:  Alexandro Rodríguez-Rojas; María D Maciá; Alejandro Couce; Cristina Gómez; Alfredo Castañeda-García; Antonio Oliver; Jesús Blázquez
Journal:  PLoS One       Date:  2010-04-15       Impact factor: 3.240

6.  Penicillin-Binding Protein 3 Is Essential for Growth of Pseudomonas aeruginosa.

Authors:  Wei Chen; Yong-Mei Zhang; Christopher Davies
Journal:  Antimicrob Agents Chemother       Date:  2016-12-27       Impact factor: 5.191

Review 7.  Antibacterial-resistant Pseudomonas aeruginosa: clinical impact and complex regulation of chromosomally encoded resistance mechanisms.

Authors:  Philip D Lister; Daniel J Wolter; Nancy D Hanson
Journal:  Clin Microbiol Rev       Date:  2009-10       Impact factor: 26.132

8.  AMINOGLYCOSIDE RESISTANCE GENES IN Pseudomonas aeruginosa ISOLATES FROM CUMANA, VENEZUELA.

Authors:  Bertinellys Teixeira; Hectorina Rodulfo; Numirin Carreño; Militza Guzmán; Elsa Salazar; Marcos De Donato
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2016-03-22       Impact factor: 1.846

9.  The impact of membrane lipid composition on macrophage activation in the immune defense against Rhodococcus equi and Pseudomonas aeruginosa.

Authors:  Axel Schoeniger; Stephanie Adolph; Herbert Fuhrmann; Julia Schumann
Journal:  Int J Mol Sci       Date:  2011-11-02       Impact factor: 5.923

10.  Pseudomonas aeruginosa acquisition on an intensive care unit: relationship between antibiotic selective pressure and patients' environment.

Authors:  Alexandre Boyer; Adélaïde Doussau; Rodolphe Thiébault; Anne Gaëlle Venier; Van Tran; Hélène Boulestreau; Cécile Bébéar; Frédéric Vargas; Gilles Hilbert; Didier Gruson; Anne Marie Rogues
Journal:  Crit Care       Date:  2011-02-09       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.